Tag: Taro Pharmaceutical Industries
Sun Pharmaceutical proposes revised offer for Taro Pharmaceutical acquisition
In a notable development within the pharmaceutical industry, Sun Pharmaceutical Industries Limited has expressed a non-binding interest in acquiring shares of Taro Pharmaceutical Industries Ltd. ... Read More
Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The ... Read More
Taro scraps onychomycosis drug Novexatin deal with NovaBiotics
Taro Pharmaceutical Industries said that it has scrapped its licensing agreement with Scottish biotech company NovaBiotics for Novexatin after the investigational onychomycosis drug failed to ... Read More